Clariness

20/05/2025

For 20 years, Clariness has been proud to bring patients and research closer together - helping advance medical therapies that change lives.

Today, on International , we’re spotlighting one of the most urgent challenges in clinical research: and inclusion.

Our latest blog, based on insights from the largest global survey on clinical trial diversity to date, reveals a critical truth: It’s not a lack of willingness holding back diverse participation - but practical and psychological barriers that continue to stand in the way. 🌈

📖 Read the full blog here: https://vist.ly/3n4sdzm

19/05/2025

At Clariness, we’re using to transform patient recruitment with AI-powered insights.

Read the press release here: https://vist.ly/3n4ps8r

Leveraging on our extensive 20 years of performance data, our teams can quickly design smarter, more cost-effective recruitment funnels - tailored by geography, demographics and real-world site performance.

In partnership with a top-20 pharmaceutical company, our AI-driven approach to a Phase III migraine trial cut recruitment costs by 50% and significantly accelerated enrollment timelines.

💬 "It’s inspiring to see how Clariness is using Amazon QuickSight to transform their patient recruitment processes. By using AI to unlock the full potential of their extensive datasets, Clariness is driving greater efficiency and improved decision-making” said Lisa Dahl, Territory Manager at Amazon.

💬 “We’re combining AI with decades of expertise to deliver faster, smarter strategies for our clients,” says Dilek Denizli, VP of Recruitment Strategy.

15/05/2025

Join us in Berlin for an in-person workshop exploring innovative ways to increase patient involvement in clinical trials across Germany.

Secure your spot today👉 https://bit.ly/3RIcMUf

Held in collaboration with Bundesverband der Pharmazeutischen Industrie & Verband Forschender Arzneimittelhersteller e.V. (VFA), this event brings together key stakeholders from across the clinical research landscape.

Topics covered include:
✅ Strategies to better understand patient needs and motivations
✅ Empowering physicians and study sites to support patient recruitment
✅ Leveraging digital tools and multi-channel outreach to improve study visibility
✅ Success stories and case studies from patient-centric recruitment campaigns

View the full program here: https://bit.ly/3RIcMUf

*This event is exclusively open to members of VFA and BPI, as well as Clariness customers.

14/05/2025

Are you ready to explore how Germany’s new Medical Research Act will reshape the European clinical trial landscape? https://bit.ly/4kiIKCG

Join us for an exclusive webinar as we explore this groundbreaking reform - set to streamline approvals, reduce bureaucracy and accelerate trial ex*****on - unlocking Germany’s full potential as a key hub for innovation.

📅 Date: 6 June 2025
🕒 Time: 3:30 PM (CEST)

Register your place here: https://bit.ly/4kiIKCG

You’ll learn:
✅ How the new framework improves trial efficiency
✅ What this means for patient recruitment & retention
✅ Practical insights on leveraging Germany for your global trial strategy

Joined by industry leading experts:
🎙️ Dr. Michael Busse, Head of Clinical Research at Boehringer Ingelheim
🎙️ Dr. Susanne Busta, Head of Clinical Operations DACH at Bristol-Myers Squibb
🎙️ Dr. Thorsten Ruppert, Senior Manager Research, Development and Innovation at the vfa (National association for German pharmaceuticals)
🎙️ Moritz Kloss, SVP Registry & Local Markets, Clariness

14/05/2025

We’re looking forward to attending Patients as Partners Europe in London next week!

Our Senior Director, Matt Hunt will be there and if you’re attending too, we’d love to connect. Let’s chat about how we can strengthen patient involvement and make clinical research more inclusive.

📅 Book a meeting with us here: https://vist.ly/3n4avam
💬 Or drop us a DM and we’ll find a time that works!

08/05/2025

New blog: How to increase clinical trial diversity 🌈 - https://vist.ly/3n3spmc

Our latest blog, based on the largest global survey on clinical trial diversity to date (6,000+ participants across 9 countries), reveals that it’s not a lack of willingness holding back diverse participation - but practical and psychological barriers that continue to stand in the way.

Some of the key findings include:

✅72% of respondents said they’d participate in a trial - but only 24% had
✅ 96% of Black respondents expressed an interest in participating in a clinical trial - the highest of any minority group
✅ Non-binary participants reported the highest dissatisfaction with healthcare providers (over 50% cited fear or insensitivity from doctors)
✅“Learning more about my condition or treatment” was the top motivation for participation (42%)

This blog doesn’t just highlight the barriers, it offers data-backed solutions to make trials more inclusive and accessible.

📖 Read the full analysis here: https://vist.ly/3n3spmc

Authors:
Shambhavi Chidambaram, Patient Insights Manager, Clariness
Joseph Yeomans, SVP Marketing & Growth, Clariness

06/05/2025

It's , and as part of our commitment to advancing therapies for people living with , we're proud to have supported over 30 clinical studies that are helping to shape the future of treatment.

Learn more about our contribution here: https://vist.ly/3n3n3r3

06/05/2025

💬 The 5 latest real client questions are in - and our experts at Clariness didn’t hold back!

Read the answers here: https://clariness.com/faqs/?utm_campaign=finallyansweredquestions&utm_medium=social&utm_source=linkedin

We hope you find these answers useful! Got a question on your mind? Drop it below or DM us!

23/04/2025

💬 "Are your patient funnels guesswork?"
📣 "How much do you rely on Facebook for patient advertising?"

At Clariness, these are just a couple of the upfront questions we get from pharmaceutical companies every day – and we're here for it.

Every two weeks, we're pulling back the curtain and sharing 5 real questions from our clients, along with the honest answers from our team.

Read the answers here: https://vist.ly/3m2juuk

Have a burning question of your own? Drop it below or DM us!

07/04/2025

Celebrating World Health Day! 🌍

This year, the focus is on maternal and newborn health - a cause that resonates deeply with us at Clariness. We are committed to advancing women’s health and pediatric research, ensuring better outcomes for mothers and their babies.
In the past year, 62% of our randomized trial patients were women - that’s 20% above the industry average. This reflects our dedication to improving healthcare access and driving inclusive clinical research.

Together, we can shape a healthier future for all.

11/03/2025

We’re thrilled to announce that Clariness has acquired Mondosano, a leading digital health platform! This strategic move expands our European patient reach, giving more individuals access to clinical trials while enhancing recruitment for our customers. As Michael Stadler, Founder & CEO of Clariness, puts it:

"This acquisition is not just about growth - it’s about impact. By combining resources, we can enroll more patients in clinical trials and bring innovative treatments to those who need them most."

This acquisition builds on our mission to streamline global patient recruitment, following our acquisition of Viomedo in 2016.

Together, we’re shaping the future of clinical trial access!

Hamburg, Germany 11 March 2025 – Clariness today announces its acquisition of Mondosano, a digital health platform. This acquisition provides …

08/03/2025

In honour of International Women's Day, we're proud to support women in clinical research and advancing their participation and representation in clinical trials, worldwide. This past year, 62% of all participants in studies we've supported were women (significantly above the global average of 41%).

At Clariness, we're equally committed to championing women within our own company, with 60% of our team and 50% of our leadership made up of women!

We're committed to breaking barriers, driving inclusivity, and creating more opportunities for women - in clinical trials and beyond.